Glucagon-Like Peptide 1: A Predictor of Type 2 Diabetes?

BACKGROUND: The incretin effect is impaired in patients with type 2 diabetes. AIM: To assess the relation between the incretin hormone GLP-1 and the prediabetic subtypes: impaired fasting glucose (IFG), impaired glucose tolerance (IGT), and the combined IFG/IGT to investigate whether a low GLP-1 res...

Descripción completa

Detalles Bibliográficos
Autores principales: Larsen, Matthias Ploug, Torekov, Signe Sørensen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610892/
https://www.ncbi.nlm.nih.gov/pubmed/29082261
http://dx.doi.org/10.1155/2017/7583506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610892/
https://www.ncbi.nlm.nih.gov/pubmed/29082261
http://dx.doi.org/10.1155/2017/7583506

Ejemplares similares